Free Trial

Life Science REIT (LABS) Competitors

Life Science REIT logo
GBX 38.20 +0.10 (+0.26%)
(As of 11:53 AM ET)

LABS vs. THRL, IHR, MXF, AGR, PHP, ESP, SHED, MLI, RDI, and LOK

Should you be buying Life Science REIT stock or one of its competitors? The main competitors of Life Science REIT include Target Healthcare REIT (THRL), Impact Healthcare REIT (IHR), Medicx Fund (MXF), Assura (AGR), Primary Health Properties (PHP), Empiric Student Property (ESP), Urban Logistics REIT (SHED), Industrials REIT (MLI), Rdi Reit (RDI), and Lok'nStore Group (LOK). These companies are all part of the "real estate" sector.

Life Science REIT vs.

Life Science REIT (LON:LABS) and Target Healthcare REIT (LON:THRL) are both small-cap real estate companies, but which is the better stock? We will compare the two companies based on the strength of their risk, valuation, dividends, analyst recommendations, profitability, media sentiment, institutional ownership, community ranking and earnings.

Target Healthcare REIT received 89 more outperform votes than Life Science REIT when rated by MarketBeat users. However, 80.00% of users gave Life Science REIT an outperform vote while only 65.03% of users gave Target Healthcare REIT an outperform vote.

CompanyUnderperformOutperform
Life Science REITOutperform Votes
4
80.00%
Underperform Votes
1
20.00%
Target Healthcare REITOutperform Votes
93
65.03%
Underperform Votes
50
34.97%

Life Science REIT pays an annual dividend of GBX 2 per share and has a dividend yield of 5.2%. Target Healthcare REIT pays an annual dividend of GBX 6 per share and has a dividend yield of 7.1%. Life Science REIT pays out -3,333.3% of its earnings in the form of a dividend. Target Healthcare REIT pays out 5,000.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Target Healthcare REIT has a net margin of 104.99% compared to Life Science REIT's net margin of -108.85%. Target Healthcare REIT's return on equity of 10.87% beat Life Science REIT's return on equity.

Company Net Margins Return on Equity Return on Assets
Life Science REIT-108.85% -7.20% 1.25%
Target Healthcare REIT 104.99%10.87%3.86%

Target Healthcare REIT has higher revenue and earnings than Life Science REIT. Life Science REIT is trading at a lower price-to-earnings ratio than Target Healthcare REIT, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Life Science REIT£19.94M6.71-£21.71M-£0.06-636.67
Target Healthcare REIT£69.55M7.53£73.02M£0.12703.33

Life Science REIT has a beta of 0.08, suggesting that its stock price is 92% less volatile than the S&P 500. Comparatively, Target Healthcare REIT has a beta of 0.44, suggesting that its stock price is 56% less volatile than the S&P 500.

Life Science REIT currently has a consensus price target of GBX 46.50, indicating a potential upside of 21.73%. Given Life Science REIT's stronger consensus rating and higher possible upside, equities research analysts clearly believe Life Science REIT is more favorable than Target Healthcare REIT.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Life Science REIT
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67
Target Healthcare REIT
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

67.3% of Life Science REIT shares are owned by institutional investors. Comparatively, 69.4% of Target Healthcare REIT shares are owned by institutional investors. 7.0% of Life Science REIT shares are owned by insiders. Comparatively, 0.1% of Target Healthcare REIT shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Life Science REIT and Life Science REIT both had 1 articles in the media. Target Healthcare REIT's average media sentiment score of 0.75 beat Life Science REIT's score of 0.67 indicating that Target Healthcare REIT is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Life Science REIT
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Target Healthcare REIT
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Target Healthcare REIT beats Life Science REIT on 13 of the 19 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LABS vs. The Competition

MetricLife Science REITREIT IndustryReal Estate SectorLON Exchange
Market Cap£133.70M£1.26B£1.42B£1.41B
Dividend Yield6.21%7.41%7.06%11.77%
P/E Ratio-636.67187.12268.601,563.33
Price / Sales6.71512.97902.14297,901.50
Price / CashN/A44.1457.9533.22
Price / Book0.471.171.132.87
Net Income-£21.71M-£53.40M-£44.93M£153.33M
7 Day Performance0.53%-3.62%-1.50%18.10%
1 Month Performance-2.05%-4.00%-2.63%18.15%
1 Year Performance-38.59%-0.39%2.91%23.31%

Life Science REIT Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LABS
Life Science REIT
1.9496 of 5 stars
GBX 38.20
+0.3%
GBX 46.50
+21.7%
-39.7%£133.70M£19.94M-636.67N/A
THRL
Target Healthcare REIT
N/AGBX 84.20
-2.1%
N/A-0.4%£522.24M£69.55M716.67N/A
IHR
Impact Healthcare REIT
N/AGBX 87.30
-1.1%
GBX 114
+30.6%
-1.6%£361.75M£53.51M793.64N/A
MXF
Medicx Fund
N/AGBX 96.40
flat
N/AN/A£0.00N/A0.00N/AHigh Trading Volume
AGR
Assura
3.1409 of 5 stars
GBX 38.94
-0.5%
GBX 50.67
+30.1%
-14.4%£1.27B£157.80M-3,906.0084
PHP
Primary Health Properties
1.2032 of 5 stars
GBX 92.80
-0.9%
GBX 107.50
+15.8%
-7.8%£1.24B£177.80M-9,360.0058
ESP
Empiric Student Property
N/AGBX 83.40
-1.5%
N/A-10.6%£503.33M£81.60M936.67150
SHED
Urban Logistics REIT
2.3367 of 5 stars
GBX 105.72
-1.2%
GBX 142
+34.3%
-16.1%£498.99M£59.95M2,114.44N/ANews Coverage
High Trading Volume
MLI
Industrials REIT
N/AGBX 168
flat
N/AN/A£494.79M£50.19M1,050.005,140Positive News
RDI
Rdi Reit
N/AGBX 121.20
flat
N/AN/A£462.34M£68.40M-4.442,020
LOK
Lok'nStore Group
N/AGBX 1,105
flat
N/A+34.4%£356.58M£27.73M8,500.00193

Related Companies and Tools


This page (LON:LABS) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners